ENO2 and neoplasm: To enhance prognostic accuracy, we took an innovative approach by combining preoperative PNI—identified as the most effective marker among nutritional and immune indices—with traditional tumor markers (CEA, CA19‐9, NSE, and CYFRA21‐1) in predicting postoperative recurrence for IB‐stage NSCLC.